Metabolomics News

Performing Metabolomic and Functional Proteomic Analyses on a Heterogenous Cancer Cell Population  The Scientist

PLOS Papers on Plasmodium Falciparum Populations, Scabies Molecular Diagnostics, More  GenomeWeb

Metabolomics Market to Witness Growth Acceleration by Top Key Players Like Agilent Technologies Inc., Thermo Fisher Scientific Inc., Bruker Corporation, Danaher Corporation – KSU | The Sentinel Newspaper  KSU | The Sentinel Newspaper

Hologic further expands diagnostics reach with $159M Diagenode tuck-in buy  FierceBiotech

Thermo Fisher Scientific Introduces New GC-MS Instrument  Technology Networks

Rebus Biosystems launches spatial transcriptomics analysis platform  FierceBiotech

Gas Chromatography High-Resolution Mass Spectrometer Offers New Standard of Performance for Research Laboratories  PRNewswire

Metabolomics Market SWOT Analysis including key players Bruker, LECO Corporation, WATERS – Express Keeper  Express Keeper

Global Metabolomics Biomarker Market 2020 Industry Status and Outlook, Competitive Landscape and Growth by 2025  The Courier

Thermo Fisher Scientific Introduces New GC-MS Instrument  Technology Networks

Metabolomics Market Size 2021 | Global Industry Share, Trends, Growth Insights, SWOT Analysis by Top Key Vendors and Forecast to 2027  The Bisouv Network

SARS-CoV-2 modulates host cell central carbon metabolism for reproduction  News-Medical.Net

Metabolomics Market 2021 Global Industry Size, Reviews, Segments, Revenue, and Forecast to 2027 – NeighborWebSJ  NeighborWebSJ

Metabolomics Market Analysis, and Future Trends to 2028 – The Bisouv Network  The Bisouv Network

TOPMed: Analyzing human genomes to understand mutations, human evolution  University of Michigan News

Have a case of a COVID variant? No one is going to tell you  FierceBiotech

Axonics acquires Contura and its incontinence hydrogel injection for $200M  FierceBiotech

Roivant Sciences to absorb Silicon Therapeutics into its VantAI outfit with $450M-plus deal  FierceBiotech

Artiva, fresh from Merck pact, raises $120M for NK therapy R&D  FierceBiotech

Gossamer Bio seeking out partners for failed DP2 antagonist, says it has 'viable path forward'  FierceBiotech